研究下颌第三磨牙水平撞击后下牙槽神经损伤引起的低痛症服用维生素B12的持续时间:回顾性研究

IF 0.4 Q4 DENTISTRY, ORAL SURGERY & MEDICINE
Takumi Shimura, Ken-ichiro Sakata, Hiroyuki Hato, Haruhisa Watanabe, Takuya Asaka, Jun Sato, Yoshimasa Kitagawa
{"title":"研究下颌第三磨牙水平撞击后下牙槽神经损伤引起的低痛症服用维生素B12的持续时间:回顾性研究","authors":"Takumi Shimura,&nbsp;Ken-ichiro Sakata,&nbsp;Hiroyuki Hato,&nbsp;Haruhisa Watanabe,&nbsp;Takuya Asaka,&nbsp;Jun Sato,&nbsp;Yoshimasa Kitagawa","doi":"10.1016/j.ajoms.2024.07.010","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to assess the time to cure of hypoesthesia caused by inferior alveolar nerve (IAN) injury after horizontally impacted mandibular third molar (M3) extraction under continuous administration of mecobalamin, a vitamin B12 preparation, and factors that influence the time to cure.</div></div><div><h3>Methods</h3><div>This was a single-center retrospective study including 33 patients who experienced hypoesthesia after horizontally impacted M3 extraction and were treated with continuous oral administration of mecobalamin alone. The patients were divided into cured (n = 28) and uncured groups (n = 5). Demographic and clinical data were collected and analyzed.</div></div><div><h3>Results</h3><div>Of the 33 patients, 5 (15 %) reported uncured hypoesthesia. The median time to cure of hypoesthesia with mecobalamin administration was 33 (range, 6–202) days, and no cure beyond 7 months was reported. Age (≥30 years), Pell and Gregory classification (Position), and presence of Rood and Shehab signs (\"interruption of white line of canal\" and \"diversion of canal\") were significantly associated with prolonged time to cure.</div></div><div><h3>Conclusions</h3><div>It may be necessary to evaluate the efficacy of mecobalamin for IAN injury after horizontally impacted M3 extraction approximately 30 days after the initiation of administration and consider treatment modification or additional treatment within approximately 7 months.</div></div>","PeriodicalId":45034,"journal":{"name":"Journal of Oral and Maxillofacial Surgery Medicine and Pathology","volume":"37 1","pages":"Pages 195-200"},"PeriodicalIF":0.4000,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Examination of the duration of vitamin B12 administration for hypoesthesia caused by inferior alveolar nerve injury after horizontally impacted mandibular third molar: A retrospective study\",\"authors\":\"Takumi Shimura,&nbsp;Ken-ichiro Sakata,&nbsp;Hiroyuki Hato,&nbsp;Haruhisa Watanabe,&nbsp;Takuya Asaka,&nbsp;Jun Sato,&nbsp;Yoshimasa Kitagawa\",\"doi\":\"10.1016/j.ajoms.2024.07.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>This study aimed to assess the time to cure of hypoesthesia caused by inferior alveolar nerve (IAN) injury after horizontally impacted mandibular third molar (M3) extraction under continuous administration of mecobalamin, a vitamin B12 preparation, and factors that influence the time to cure.</div></div><div><h3>Methods</h3><div>This was a single-center retrospective study including 33 patients who experienced hypoesthesia after horizontally impacted M3 extraction and were treated with continuous oral administration of mecobalamin alone. The patients were divided into cured (n = 28) and uncured groups (n = 5). Demographic and clinical data were collected and analyzed.</div></div><div><h3>Results</h3><div>Of the 33 patients, 5 (15 %) reported uncured hypoesthesia. The median time to cure of hypoesthesia with mecobalamin administration was 33 (range, 6–202) days, and no cure beyond 7 months was reported. Age (≥30 years), Pell and Gregory classification (Position), and presence of Rood and Shehab signs (\\\"interruption of white line of canal\\\" and \\\"diversion of canal\\\") were significantly associated with prolonged time to cure.</div></div><div><h3>Conclusions</h3><div>It may be necessary to evaluate the efficacy of mecobalamin for IAN injury after horizontally impacted M3 extraction approximately 30 days after the initiation of administration and consider treatment modification or additional treatment within approximately 7 months.</div></div>\",\"PeriodicalId\":45034,\"journal\":{\"name\":\"Journal of Oral and Maxillofacial Surgery Medicine and Pathology\",\"volume\":\"37 1\",\"pages\":\"Pages 195-200\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2024-08-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Oral and Maxillofacial Surgery Medicine and Pathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S221255582400142X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oral and Maxillofacial Surgery Medicine and Pathology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221255582400142X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0

摘要

本研究旨在评估下颌第三磨牙(M3)水平撞击拔除术后,在持续服用维生素 B12 制剂甲钴胺的情况下,下牙槽神经(IAN)损伤引起的低麻痹的治愈时间,以及影响治愈时间的因素。患者被分为治愈组(28 人)和未治愈组(5 人)。收集并分析了人口统计学和临床数据。服用甲钴胺治愈麻痹的中位时间为 33 天(6-202 天),没有超过 7 个月的治愈报告。年龄(≥30 岁)、Pell 和 Gregory 分级(Position)以及 Rood 和 Shehab 征兆("管白线中断 "和 "管分流")的存在与治愈时间的延长有显著相关性。结论可能有必要在开始用药后 30 天左右评估甲钴胺对水平撞击式 M3 拔牙后 IAN 损伤的疗效,并考虑在大约 7 个月内调整治疗方法或进行额外治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Examination of the duration of vitamin B12 administration for hypoesthesia caused by inferior alveolar nerve injury after horizontally impacted mandibular third molar: A retrospective study

Objective

This study aimed to assess the time to cure of hypoesthesia caused by inferior alveolar nerve (IAN) injury after horizontally impacted mandibular third molar (M3) extraction under continuous administration of mecobalamin, a vitamin B12 preparation, and factors that influence the time to cure.

Methods

This was a single-center retrospective study including 33 patients who experienced hypoesthesia after horizontally impacted M3 extraction and were treated with continuous oral administration of mecobalamin alone. The patients were divided into cured (n = 28) and uncured groups (n = 5). Demographic and clinical data were collected and analyzed.

Results

Of the 33 patients, 5 (15 %) reported uncured hypoesthesia. The median time to cure of hypoesthesia with mecobalamin administration was 33 (range, 6–202) days, and no cure beyond 7 months was reported. Age (≥30 years), Pell and Gregory classification (Position), and presence of Rood and Shehab signs ("interruption of white line of canal" and "diversion of canal") were significantly associated with prolonged time to cure.

Conclusions

It may be necessary to evaluate the efficacy of mecobalamin for IAN injury after horizontally impacted M3 extraction approximately 30 days after the initiation of administration and consider treatment modification or additional treatment within approximately 7 months.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
129
审稿时长
83 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信